Cytotoxic T cells

被引:288
作者
Andersen, Mads Hald
Schrama, David
Straten, Per thor
Becker, Juergen C.
机构
[1] Univ Wurzburg, Klin & Poliklin Dermatol Allergol & Venerol, Sch Med, Dept Dermatol, D-97080 Wurzburg, Germany
[2] Danish Canc Soc, Inst Canc Biol, Tumor Immunol Grp, Copenhagen, Denmark
关键词
D O I
10.1038/sj.jid.5700001
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The immune system is a complex arrangement of cells and molecules that preserve the integrity of the organism by elimination of all elements judged dangerous. Within the immune system, a humoral and a cellular as well as an innate and an adaptive arm can be differentiated. The key players of adaptive cellular immune responses are T lymphocytes in general and, for the effector function, cytotoxic T lymphocytes (CTLs) in particular. T lymphocytes arise in the bone marrow and migrate to the thymus for maturation. During this process, T cells somatically rearrange gene segments, eventually leading to the expression of a unique antigen-binding molecule, the T-cell receptor (TCR). This receptor allows them to monitor all cells of the body, ready to destroy any cell posing a threat to the organism. Cytotoxicity is exerted directly through the Fas or perforin pathway and/or indirectly by the release of cytokines. Obviously, the activity of such a potent cell is tightly regulated. Indeed, a predominance of stimulatory over inhibitory signals is required for effective immune responses to pathogens, and a predominance of inhibitory over stimulatory signals is required for maintenance of self-tolerance. Still, several situations occur in which an inappropriate CTL response leads to either autoimmune disease or persistence of pathogens.
引用
收藏
页码:32 / 41
页数:10
相关论文
共 81 条
[21]   Skewed maturation of memory HIV-specific CD8 T lymphocytes [J].
Champagne, P ;
Ogg, GS ;
King, AS ;
Knabenhans, C ;
Ellefsen, K ;
Nobile, M ;
Appay, V ;
Rizzardi, GP ;
Fleury, S ;
Lipp, M ;
Förster, R ;
Rowland-Jones, S ;
Sékaly, RP ;
McMichael, AJ ;
Pantaleo, G .
NATURE, 2001, 410 (6824) :106-111
[22]  
Ciernik IF, 1996, CLIN CANCER RES, V2, P877
[23]  
De Panfilis G, 1998, EXP DERMATOL, V7, P121
[24]  
Eggert AO, 2002, EUR J IMMUNOL, V32, P122, DOI 10.1002/1521-4141(200201)32:1<122::AID-IMMU122>3.0.CO
[25]  
2-C
[26]  
Farzati B, 2005, CLIN EXP RHEUMATOL, V23, P43
[27]   Response of Mycobacterium tuberculosis to reactive oxygen and nitrogen intermediates [J].
Garbe, TR ;
Hibler, NS ;
Deretic, V .
MOLECULAR MEDICINE, 1996, 2 (01) :134-142
[28]   Immunoregulation of allergic contact dermatitis [J].
Girolomoni, G ;
Gisondi, P ;
Ottaviani, C ;
Cavani, A .
JOURNAL OF DERMATOLOGY, 2004, 31 (04) :264-270
[29]   The B7 family revisited [J].
Greenwald, RJ ;
Freeman, GJ ;
Sharpe, AH .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :515-548
[30]   Hypopigmentary skin disorders -: Current treatment options and future directions [J].
Hartmann, A ;
Bröcker, EB ;
Becker, JC .
DRUGS, 2004, 64 (01) :89-107